title: [Value of pleiotropic effects of angiotensin-converting enzyme inhibitors].
abstract: Recently the pleiotropic effects of angiotensin-converting enzyme inhibitors which lay beyond their pure antihypertensive effects are widely discussed. Antiproliferative, antiatherosclerotic, antiproliferative and antiarrhythmic properties, as well as positive effects on hemostasis and endothelial function allows angiotensin-converting enzyme inhibitors to occupy very important position among other cardiovascular medications and to have a number of indications: arterial hypertension, congestive heart failure, myocardial infarction, left ventricular hypertrophy and patients with high risk of cardiovascular disease.
authors.forename: N Sh
authors.initials: NSh
authors.lastname: Zagidullin
authors.forename: K F
authors.initials: KF
authors.lastname: Valeeva
authors.forename: F
authors.initials: F
authors.lastname: Gassanov
authors.forename: Sh Z
authors.initials: ShZ
authors.lastname: Zagidullin
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D050197:Atherosclerosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D005342:Fibrinolysis / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D058226:Plaque, Atherosclerotic / Q000188:drug therapy* / Q000378:metabolism; D020257:Ventricular Remodeling / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents